News

  1. diaago Expands Automation Offering Through Partnership With PAA, Introducing The KX-2 Collaborative Robot 9/4/2025

    diaago, a stocking distributor of laboratory consumables and equipment, has added innovations from Peak Analysis & Automation (PAA) to its automation portfolio, marking another strategic partnership to support the growing need for versatile automation solutions.

  2. U.S. Department Of Energy Announces $6.9M In Projects To Support Effective Community Waste-To-Energy Strategies For Local Transportation Needs 1/7/2025

    The U.S. Department of Energy's (DOE) Bioenergy Technologies Office (BETO) and Vehicle Technologies Office (VTO) announced $6.9M in funding for nine projects to support local waste-to-energy management solutions for transportation energy needs.

  3. Nordic nRF54L15 SoC-Powered Bluetooth 6.0 Beacon Enables Precision Asset Tracking And Navigation Applications 5/19/2025

    Leading IoT device manufacturer, MOKO SMART, has launched a beacon solution powered by Nordic Semiconductor’s next generation nRF54L15 SoC, enabling highly reliable positioning across wide indoor and outdoor areas.

  4. Research Collaboration Between RIT And Cornell Produces New Technique To Enhance Sensors And Photonic Devices 1/30/2025

    Researchers have discovered new ways to bend light to improve optical applications such as sensors, displays, and next-generation photonic devices.

  5. Lisata Therapeutics Announces Research License With Catalent 4/15/2025

    Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that the Company has entered into a research license with Catalent, Inc. (“Catalent”) to evaluate, in a preclinical setting, the efficacy of Lisata's iRGD cyclic peptide product candidate, certepetide, as a payload used in the context of Catalent’s SMARTag® antibody-drug conjugate (“ADC”) dual-payload technology platform for the treatment of difficult-to-treat-diseases, including advanced solid tumors.

  6. Jupiter Neurosciences Announces JOTROL Manufacturing Agreement With Catalent To Support Phase 2a Parkinson's Trial 2/3/2025

    Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, today announced it has entered into an agreement with Catalent Pharma Solutions, LLC ("Catalent") for the production of JOTROL™ softgel capsules to support Jupiter’s upcoming Phase 2a clinical trial in Parkinson’s disease.

  7. Anritsu Supports Evaluation Of 5G NR NTN Devices For Satellite-Based Communications 7/29/2025

    Anritsu Corporation, a global leader in test and measurement solutions, is pleased to announce that its Radio Communication Test Station MT8000A, a measurement solution for 5G devices such as smartphones, now supports evaluation of 5G NR NTN devices for non-terrestrial networks (NTN), which enables communication via satellite.

  8. FARO Technologies Pushes 3D Metrology Forward With New FARO Leap ST 1/23/2025

    FARO® Technologies, Inc. (Nasdaq: FARO) has entered a new category of handheld scanning with the launch of FARO Leap ST®.

  9. Brown Astronomers Create New Technique To Eliminate Signals Disrupting Sensitive Radio Telescopes 2/12/2025

    Astronomers sifting through data from the Murchison Widefield Array, a radio telescope in Western Australia, found themselves confronting an unexpected mystery.

  10. Wireless Broadband Alliance Wi-Fi 7 Trials Demonstrate Significant Performance Gains For Real-World Enterprise Environments 5/7/2025

    The Wireless Broadband Alliance (WBA), the global industry body dedicated to driving the seamless and interoperable service experience of Wi-Fi across the global wireless ecosystem, has today announced the results of Wi-Fi 7 industry trials in Enterprise Scenarios, conducted in collaboration with AT&T, CommScope (RUCKUS Networks), and Intel.